<qa>  What is the safety and immunogenicity of trivalent, surface antigen, inactivatedThe present study is designed to evaluate the safety and immunogenicity of trivalent, surface antigen, inactivated influenza vaccine in 2 age cohorts: 18 to 60 years and 61 years. 